Settlement Reached in Whistleblower Case Against Semler and Bard Over Fraudulent Medicare Billing Semler Scientific and Bard Peripheral Vascular settle with whistleblowers for $36.95 million over fraudulent Medicare claims. The case raises questions about patient safety.

Settlement Reached in Whistleblower Case Against Semler and Bard Over Fraudulent Medicare Billing #United_States #Philadelphia #Semler_Scientific #Medicare_Fraud #Bard_Vascular